DIA China 2024 Annual Meeting
The upcoming DIA China 2024 Meeting will continue to bring the key focuses on Regulatory Innovation, Science & Technology Innovation, and Talent Innovation to forward looking the trends of globalization and localization of drug development & innovation.
Join us at Booth #CE05 and dive into the future of drug development & innovation with Ergomed’s pioneering pharmaceutical safety services and global CRO expertise, particularly in oncology and rare diseases.
Meet our Experts at #DIAChina24!
Junbao Qiu
PrimeVigilance Director of Operations
Lina Svedlund
Ergomed Director of Business Development & Alliance Management
Daorong Zhang
Ergomed Business Development
We look forward to seeing you.